158 related articles for article (PubMed ID: 16180361)
1. [Dihydropyridines for treatment of arterial hypertension].
Bareza N; Gasser S; Toferer E; Scheer E; Pruthi D; Gasser R
Pharm Unserer Zeit; 2005; 34(5):388-91. PubMed ID: 16180361
[No Abstract] [Full Text] [Related]
2. [Hypertension in type 2 diabetic patients. Calcium antagonist supports the left heart].
MMW Fortschr Med; 2001 Jun; 143(25):58. PubMed ID: 11469003
[No Abstract] [Full Text] [Related]
3. [Drug information about lercanidipine. A new dihydropyridine calcium antagonist for the treatment of arterial hypertension].
Christensen KL
Ugeskr Laeger; 2005 Jan; 167(2):153-5. PubMed ID: 15697124
[No Abstract] [Full Text] [Related]
4. Cardiovascular advantages of a third generation calcium antagonist. Symposium on lacidipine. Foreword.
Zanchetti A
Drugs; 1999; 57 Suppl 1():2 p preceding 1. PubMed ID: 10529077
[No Abstract] [Full Text] [Related]
5. Calcium channel blocker.
Li CJ; Shi ZD
Clin Ther; 2010 Feb; 32(2):396; author reply 397. PubMed ID: 20206797
[No Abstract] [Full Text] [Related]
6. [Also for problem cases; successful first line therapy].
MMW Fortschr Med; 2005 Feb; 147(5):47. PubMed ID: 15766030
[No Abstract] [Full Text] [Related]
7. Watanidipine. AE 0047, Calbren, GJ 0956, Vatanidipine.
Drugs R D; 2002; 3(5):331-6. PubMed ID: 12455154
[No Abstract] [Full Text] [Related]
8. Lacidipine. Aponil, Caldine, GR 43659, GR 43659X, GX 1048, Lacimen, Lacipil, Lacirex, Midotens, Motens, SN 305, Viapres.
Drugs R D; 2002; 3(5):324-30. PubMed ID: 12455153
[No Abstract] [Full Text] [Related]
9. Calcium antagonists "some agents lower blood pressure and still put the heart at risk"?
Leenen FH
Clin Exp Hypertens; 1999; 21(5-6):823-34. PubMed ID: 10423105
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive and metabolic effects of lacidipine in patients with NIDDM and/or hypertension.
Galeone F; Giuntoli F; Fiore G; Brunelleschi G; Saba P
J Cardiovasc Pharmacol; 1994; 23 Suppl 5():S105-7. PubMed ID: 7609495
[TBL] [Abstract][Full Text] [Related]
11. Role of dihydropyridinic calcium channel blockers in the management of hypertension.
Coca A; Mazón P; Aranda P; Redón J; Divisón JA; Martínez J; Calvo C; Galcerán JM; Barrios V; Roca-Cusachs I Coll A
Expert Rev Cardiovasc Ther; 2013 Jan; 11(1):91-105. PubMed ID: 23259449
[TBL] [Abstract][Full Text] [Related]
12. Effects of Long- and Intermediate-Acting Dihydropyridine Calcium Channel Blockers in Hypertension: A Systematic Review and Meta-Analysis of 18 Prospective, Randomized, Actively Controlled Trials.
Chaugai S; Sherpa LY; Sepehry AA; Kerman SRJ; Arima H
J Cardiovasc Pharmacol Ther; 2018 Sep; 23(5):433-445. PubMed ID: 29739234
[TBL] [Abstract][Full Text] [Related]
13. Calcium channel blockers. Lessons learned from MIDAS and other clinical trials.
Chobanian AV
JAMA; 1996 Sep; 276(10):829-30. PubMed ID: 8769595
[No Abstract] [Full Text] [Related]
14. Calcium antagonist antihypertensive treatment of non-insulin-dependent diabetics: efficacy and safety of lacidipine versus nifedipine SR.
Gulizia M; Valenti R; Platania F; D'Onofrio V; Rizzini P; Circo A
J Cardiovasc Pharmacol; 1994; 23 Suppl 5():S101-4. PubMed ID: 7609494
[TBL] [Abstract][Full Text] [Related]
15. Safety profile of lacidipine: update from a clinical trials database.
Lindholm LH; Tcherdakoff P; Zanchetti A
Drugs; 1999; 57 Suppl 1():27-9. PubMed ID: 10529080
[No Abstract] [Full Text] [Related]
16. Barnidipine compared to lercanidipine in addition to losartan on endothelial damage and oxidative stress parameters in patients with hypertension and type 2 diabetes mellitus.
Derosa G; Mugellini A; Pesce RM; D'Angelo A; Maffioli P
BMC Cardiovasc Disord; 2016 Apr; 16():66. PubMed ID: 27068332
[TBL] [Abstract][Full Text] [Related]
17. [Dihydropyridines are not the only antihypertensives. Calcium blockers in the therapy of elderly hypertensive patients].
Fortschr Med Suppl; 1989; 71():1-18. PubMed ID: 2635677
[No Abstract] [Full Text] [Related]
18. Patient adherence and the choice of antihypertensive drugs: focus on lercanidipine.
Pruijm MT; Maillard MP; Burnier M
Vasc Health Risk Manag; 2008; 4(6):1159-66. PubMed ID: 19337529
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension.
Agrawal R; Marx A; Haller H
J Hypertens; 2006 Jan; 24(1):185-92. PubMed ID: 16331117
[TBL] [Abstract][Full Text] [Related]
20. Clinical advantages of lipophilic dihydropyridines.
Mancia G; Omboni S; Zanchetti A
Blood Press Suppl; 1998; 2():23-6. PubMed ID: 9850439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
